BlackRock Fund Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $12.9M | Buy |
91,757
+15,273
| +20% | +$2.15M | ﹤0.01% | 2432 |
|
2016
Q3 | $11.2M | Buy |
76,484
+5,165
| +7% | +$754K | ﹤0.01% | 2396 |
|
2016
Q2 | $7.18M | Buy |
71,319
+794
| +1% | +$79.9K | ﹤0.01% | 2602 |
|
2016
Q1 | $9.44M | Buy |
70,525
+1,222
| +2% | +$163K | ﹤0.01% | 2383 |
|
2015
Q4 | $13.8M | Sell |
69,303
-5,058
| -7% | -$1.01M | ﹤0.01% | 2264 |
|
2015
Q3 | $11.7M | Buy |
74,361
+3,386
| +5% | +$535K | ﹤0.01% | 2303 |
|
2015
Q2 | $29M | Buy |
70,975
+13,005
| +22% | +$5.31M | 0.01% | 1883 |
|
2015
Q1 | $26.6M | Buy |
57,970
+6,944
| +14% | +$3.19M | 0.01% | 1914 |
|
2014
Q4 | $28.6M | Buy |
51,026
+29,533
| +137% | +$16.6M | 0.01% | 1846 |
|
2014
Q3 | $11.3M | Buy |
21,493
+1,087
| +5% | +$570K | ﹤0.01% | 2280 |
|
2014
Q2 | $14.2M | Buy |
20,406
+5,669
| +38% | +$3.96M | ﹤0.01% | 2200 |
|
2014
Q1 | $6.83M | Buy |
14,737
+523
| +4% | +$242K | ﹤0.01% | 2626 |
|
2013
Q4 | $4.89M | Buy |
+14,214
| New | +$4.89M | ﹤0.01% | 2840 |
|